Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs4077664 | chr1:40506534 | G/T | 7.99E-5 | 174 | 24.85 | 22.3 | 25.35 | KM Plot |
PCPG | rs4083246 | chr7:105152545 | C/T | 5.56E-5 | 177 | 20.17 | 29.43 | 2.28 | KM Plot |
PCPG | rs41266975 | chr2:241532559 | G/C | 3.44E-5 | 178 | 25.92 | 20.2 | 10.3 | KM Plot |
PCPG | rs41274094 | chr10:69713871 | G/A | 0 | 176 | 25.87 | 18.2 | 2.28 | KM Plot |
PCPG | rs41282950 | chr20:6011934 | C/T | 0 | 177 | 25.47 | 23.08 | 2.93 | KM Plot |
PCPG | rs4129403 | chr5:179476610 | A/G | 0.000213 | 178 | 24.17 | 29.95 | 14.83 | KM Plot |
PCPG | rs41296755 | chr2:217059003 | T/G | 6.76E-5 | 176 | 24.7 | 30.45 | 2.93 | KM Plot |
PCPG | rs4130692 | chr1:56345824 | C/A | 0.000285 | 170 | 25.87 | 24.15 | 15.6 | KM Plot |
PCPG | rs41313589 | chr11:74174476 | T/C | 0 | 176 | 25.6 | 19.87 | 2.93 | KM Plot |
PCPG | rs41332244 | chr3:53282033 | C/T | 0.000174 | 178 | 25.17 | 27.27 | 26.73 | KM Plot |
PCPG | rs41363748 | chr12:56696056 | C/T | 9.51E-8 | 178 | 0.8 | 27.33 | 25.08 | KM Plot |
PCPG | rs41392645 | chr12:56696742 | A/G | 9.63E-8 | 178 | 25.35 | 27.33 | 0.8 | KM Plot |
PCPG | rs41423244 | chr12:56693520 | A/C | 9.45E-8 | 178 | 0.8 | 27.3 | 25.17 | KM Plot |
PCPG | rs4149375 | chr2:24299534 | AG/A | 0.000113 | 177 | 25.4 | 27.52 | 17.43 | KM Plot |
PCPG | rs419703 | chr3:161087443 | A/G | 0.000268 | 172 | 25.87 | 19.85 | 3.17 | KM Plot |